中草药

整合代谢组学与肠道菌群分析探讨蒲公英甾醇治疗酒精性肝病的作用机制

PDF下载

中草药 | 药理与临床 2026,57(14): 5579-5590

收起

中草药 |药理与临床 2026 , 57 (14) : 5579 -5590

整合代谢组学与肠道菌群分析探讨蒲公英甾醇治疗酒精性肝病的作用机制

全屏

翁登旭^1,2, 周逸骋², 赵朵², 陈中英³, 姜程曦²

作者信息

通讯作者:

陈中英

作者简介:

翁登旭: 翁登旭，女，主管药师，研究方向为药学。E-mail:445173758@qq.com

Mechanism of taraxasterol in treatment of alcoholic liver disease integrated metabolomics and gut microbiota analysis

WENG Dengxu, ZHOU Yicheng, ZHAO Duo, CHEN Zhongying, JIANG Chengxi

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.14.019

文章导航

摘要

收起

目的从肠道菌群与肝脏代谢物角度，研究蒲公英甾醇对酒精性肝病（alcoholic liver disease，ALD）的保护作用及作用机制。方法 C57BL/6J小鼠随机分为对照组、模型组、水飞蓟宾（100 mg/kg）组和蒲公英甾醇高、低剂量（10、5 mg/kg）组，每组8只。连续给药4周，每日给药4 h后，小鼠ig 53°红星二锅头诱导ALD模型。检测血清中肝功能、肝脏组织氧化应激和炎症反应相关指标；采用苏木素-伊红（hematoxylin-eosin，HE）染色观察肝脏组织病理变化；Western blotting检测小肠组织闭锁小带蛋白-1（zonula occludens-1，ZO-1）和闭合蛋白（Occludin）蛋白表达；代谢组学和16S rRNA测序检测肝脏代谢物和肠道菌群的变化。结果与模型组比较，蒲公英甾醇显著降低ALD小鼠肝脏指数及血清中天冬氨酸氨基转移酶（aspartate aminotransferase，AST）、丙氨酸氨基转移酶（alanine aminotransferase，ALT）、三酰甘油（triglyceride，TG）水平（P＜0.05、0.01），升高肝脏组织中超氧化物歧化酶（superoxide dismutase，SOD）活性（P＜0.05、0.01），降低肝脏组织中丙二醛（malondialdehyde，MDA）、肿瘤坏死因子-α（tumor necrosis factor-α，TNF-α）和白细胞介素-6（interleukin-6，IL-6）水平（P＜0.05、0.01），改善肝脏病理变化，上调小肠组织ZO-1和Occludin的表达（P＜0.05、0.01）。16S rRNA测序分析表明，蒲公英甾醇有效调节ALD小鼠肠道菌群多样性，改善肠道微生态结构紊乱，拟杆菌属Bacteroides、双歧杆菌属Bifidobacterium和副拟杆菌属Parabacteroides等有益菌群丰度升高，埃希氏菌志贺氏菌属Escherichia Schigella、链球菌属Streptococcus等致病菌群丰度降低。代谢组学分析表明蒲公英甾醇逆转了酒精引起的肝脏代谢物紊乱，尤其是鞘脂和亚油酸代谢途径，并提高乙酸、丁酸和戊酸的水平。结论蒲公英甾醇通过调节肠道菌群和代谢物的变化，减轻肝脏炎症反应，缓解ALD。

关键词

蒲公英甾醇 / 酒精性肝病 / 代谢物 / 肠道菌群 / 氧化应激 / 炎症反应

Abstract

收起

Objective To study the protective effect and mechanism of taraxasterol on alcoholic liver disease (ALD) from the perspective of gut microbiota and liver metabolites. Methods C57BL/6J mice were randomly divided into control group, model group, silibinin (100 mg/kg) group, taraxasterol high- and low-dose (10, 5 mg/kg) groups, with eight mice in each group. After continuous administration for four weeks and daily administration for 4 h, the ALD model was induced in mice by ig 53° red star erguotou. Liver function, liver tissue oxidative stress and inflammation related indicators in serum were detected. Hematoxylin-eosin (HE) staining was used to observe pathological changes in liver tissue. Western blotting was used to detect the expressions of zonula occludin-1 (ZO-1) and Occludin proteins in small intestine tissue. Metabolomics and 16S rRNA sequencing were used to detect changes in liver metabolites and gut microbiota. Results Compared with model group, taraxasterol significantly reduced the liver index and levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), triglycerides (TG) in serum of ALD mice (P < 0.05, 0.01), increased the activity of superoxide dismutase (SOD) in liver tissue (P < 0.05, 0.01), reduced the levels of malondialdehyde (MDA), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in liver tissue (P < 0.05, 0.01), improved liver pathological changes, and upregulated the expressions of ZO-1 and Occludin in small intestine tissue (P < 0.05, 0.01). 16S rRNA sequencing analysis showed that taraxasterol effectively regulated the diversity of gut microbiota in ALD mice, improved the disorder of gut microbiota structure, and increased the abundance of beneficial bacteria such as Bacteroides, Bifidobacterium and Parabacteroides, decreased the abundance of pathogenic bacteria such as Escherichia Schilla and Streptococcus. Metabolomics analysis showed that taraxasterol reversed alcohol induced liver metabolic disorders, particularly in the sphingolipid and linoleic acid metabolic pathways, and increased levels of acetic acid, butyric acid and valeric acid. Conclusion Taraxasterol alleviates liver inflammation and alleviates ALD by regulating changes in gut microbiota and metabolites.

Key words

taraxasterol / alcoholic liver disease / metabolite / gut microbiota / oxidative stress / inflammatory response

引用本文

翁登旭, 周逸骋, 赵朵, 陈中英, 姜程曦. 整合代谢组学与肠道菌群分析探讨蒲公英甾醇治疗酒精性肝病的作用机制. 中草药, 2026 , 57 (14) : 5579 -5590 . DOI: 10.7501/j.issn.0253-2670.2026.14.019

WENG Dengxu, ZHOU Yicheng, ZHAO Duo, CHEN Zhongying, JIANG Chengxi. Mechanism of taraxasterol in treatment of alcoholic liver disease integrated metabolomics and gut microbiota analysis[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (14) : 5579 -5590 . DOI: 10.7501/j.issn.0253-2670.2026.14.019

基金

收起

温州医科大学企业横向课题 (KJHX2206)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Åberg F, Jiang Z G, Cortez-Pinto H, et al. Alcohol-associated liver disease: Global epidemiology [J]. Hepatology, 2024, 80(6): 1307-1322.
Mandrekar P, Mandal A. Pathogenesis of alcohol-associated liver disease [J]. Clin Liver Dis, 2024, 28(4): 647-661.
Bajaj J S. Alcohol, liver disease and the gut microbiota [J]. Nat Rev Gastroenterol Hepatol, 2019, 16(4): 235-246.
An L X, Wirth U, Koch D, et al. The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases [J]. J Gastrointest Surg, 2022, 26(3): 671-683.
Sun S S, Wang K, Sun L, et al. Therapeutic manipulation of gut microbiota by polysaccharides of Wolfiporia cocos reveals the contribution of the gut fungi-induced PGE₂ to alcoholic hepatic steatosis [J]. Gut Microbes, 2020, 12(1): 1830693.
Yousefi Ghale-Salimi M, Eidi M, Ghaemi N, et al. Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: In vitro study [J]. Ren Fail, 2018, 40(1): 298-305.
沈锦晟, 史玥, 夏旋, 等. 蒲公英治疗对乙酰氨基酚诱导肝损伤的研究进展[J]. 中药药理与临床, 2025, 41(6): 95-100.
Chen J F, Wu W B, Zhang M M, et al. Taraxasterol suppresses inflammation in IL-1β-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice [J]. Int Immunopharmacol, 2019, 70: 274-283.
Chen W, Da W, Li C, et al. Network pharmacology-based identification of the protective mechanisms of taraxasterol in experimental colitis [J]. Int Immunopharmacol, 2019, 71: 259-266.
Chen Y P, Liu K H, Zhang J W, et al. C-Jun NH₂-terminal protein kinase phosphorylates the Nrf2-ECH homology 6 domain of nuclear factor erythroid 2-related factor 2 and downregulates cytoprotective genes in acetaminophen-induced liver injury in mice [J]. Hepatology, 2020, 71(5): 1787-1801.
Xu L, Yu Y F, Sang R, et al. Protective effects of taraxasterol against ethanol-induced liver injury by regulating CYP2E1/Nrf2/HO-1 and NF-κB signaling pathways in mice [J]. Oxid Med Cell Longev, 2018, 2018(1): 8284107.
Ge X D, Du X X, Wang Y L, et al. Supernatants from water extraction: Ethanol precipitation of Fagopyrum tararicum seeds enhance T2DM management in mice by regulating intestinal microbial communities [J]. Foods, 2026, 15(1): 143.
刘静, 孙蓉. 小柴胡汤对非酒精性脂肪性肝炎模型小鼠的保护作用研究[J]. 中草药, 2020, 51(14): 3708-3716.
Yao J Q, Pan S Y. Polysaccharides from Citrus fruit with different mastication traits ameliorate DSS-induced ulcerative colitis by restoring intestinal barrier function and microbiota balance [J]. Foods, 2026, 15(1): 52.
Tu Y F, Zhu S, Wang J, et al. Natural compounds in the chemoprevention of alcoholic liver disease [J]. Phytother Res, 2019, 33(9): 2192-2212.
Hendrikx T, Duan Y, Wang Y H, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice [J]. Gut, 2019, 68(8): gutjnl-gu2018-317232.
Li Y, Xiao X Y, Su T, et al. Isolation, identification, and computational analysis of antioxidant peptides from deer blood and its therapeutic effects on alcoholic liver injury in mice [J]. J Funct Foods, 2025, 134: 107069.
Tang M G, Xiong L G, Huang J N, et al. Theaflavin-3,3'-digallate prevents alcoholic liver injury by suppressing hepatic TLR4/NF-κB signaling and modulating the gut-liver axis in mice [J]. J Nutr Biochem, 2025, 145: 110031.
Fang X Y, Liu X Q, Du Z H, et al. A dual-species fermentation strategy enhances the flavor profile and hepatoprotective effects of blueberry puree against alcohol induced liver injury by modulating bioactive compound composition in mice [J]. Food Res Int, 2025, 217: 116769.
Zhou L F, Xiao M, Li Y X, et al. Ursolic acid ameliorates alcoholic liver injury through attenuating oxidative stress-mediated ferroptosis and modulating gut microbiota [J]. J Agric Food Chem, 2024, 72(38): 21181-21192.
Tao K X, Peng H, Bi X, et al. Effect of Tetrastigma hemsleyanum leaves and extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injury [J]. Food Biosci, 2024, 58: 103617.
Xu W S, Dong Q, Guo Q W, et al. Camel milk and fermented camel milk prevent dextran sulfate sodium-induced ulcerative colitis via the intestinal flora-short-chain fatty acids-mucosal barrier axis in mice [J]. Front Microbiol, 2025, 16: 1723833.
de Vos W M, Tilg H, Van Hul M, et al. Gut microbiome and health: Mechanistic insights [J]. Gut, 2022, 71(5): 1020-1032.
Abenavoli L, Scarpellini E. Gut dysbiosis in alcoholic liver disease: Wonderful dilemma? [J]. Ann Hepatol, 2023, 28(5): 101123.
Ciocan D, Voican C S, Wrzosek L, et al. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis [J]. Aliment Pharmacol Ther, 2018, 48(9): 961-974.
Meroni M, Longo M, Dongiovanni P. Alcohol or gut microbiota: Who is the guilty? [J]. Int J Mol Sci, 2019, 20(18): 4568.
Bjørkhaug S T, Aanes H, Neupane S P, et al. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption [J]. Gut Microbes, 2019, 10(6): 663-675.
Huang H P, Lin Z H, Zeng Y L, et al. Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model [J]. Exp Ther Med, 2019, 18(6): 4733-4739.
王晓婷, 曹翠, 刘军锋, 等. 基于肠道菌群代谢探讨黄精多糖对酒精性肝病小鼠的保护作用[J]. 中草药, 2025, 56(16): 5814-5825.
Zhang T, Bao L J, Zhao Q, et al. Metabolomics reveals gut microbiota contribute to PPARα deficiency-induced alcoholic liver injury [J]. J Proteome Res, 2023, 22(7): 2327-2338.
Wang L, Zheng W Y, Sun Y Y, et al. Fucoidan ameliorates alcohol-induced liver injury in mice through Parabacteroides distasonis-mediated regulation of the gut-liver axis [J]. Int J Biol Macromol, 2024, 279(Pt 3): 135309.
Yu J Y, Sun J G, Sun M, et al. Protective mechanism of Coprinus comatus polysaccharide on acute alcoholic liver injury in mice, the metabolomics and gut microbiota investigation [J]. Food Sci Hum Wellness, 2024, 13(1): 401-413.
Si X, Bi J F, Chen Q Q, et al. Effect of blueberry anthocyanin-rich extracts on peripheral and hippocampal antioxidant defensiveness: The analysis of the serum fatty acid species and gut microbiota profile [J]. J Agric Food Chem, 2021, 69(12): 3658-3666.
Baltazar-Díaz T A, Riggen-Bueno V, Cortina-Romero D B, et al. Low-diversity microbiota and an increased metabolism of arginine and aromatic amino acids: A hallmark of hepatic encephalopathy in western Mexican patients with alcohol-associated cirrhosis [J]. J Appl Microbiol, 2023, 134(6): lxad113.
Baltazar-Díaz T A, González-Hernández L A, Aldana-Ledesma J M, et al. Escherichia Shigella, SCFAs, and metabolic pathways: The triad that orchestrates intestinal dysbiosis in patients with decompensated alcoholic cirrhosis from western Mexico [J]. Microorganisms, 2022, 10(6): 1231.
Liu D, Zhan J T, Wang S Q, et al. Chrysanthemum morifolium attenuates metabolic and alcohol-associated liver disease via gut microbiota and PPARα/γ activation [J]. Phytomedicine, 2024, 130: 155774.
Ma L Y, Ni Y H, Wang Z, et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice [J]. Gut Microbes, 2020, 12(1): 1832857.
Zhong X D, Cui P, Jiang J J, et al. Streptococcus, the predominant bacterium to predict the severity of liver injury in alcoholic liver disease [J]. Front Cell Infect Microbiol, 2021, 11: 649060.
Duan Y, Llorente C, Lang S, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease [J]. Nature, 2019, 575(7783): 505-511.
Shin Y, Han S, Kwon J, et al. Roles of short-chain fatty acids in inflammatory bowel disease [J]. Nutrients, 2023, 15(20): 4466.
Cai W, Wang P, Zhang R, et al. Mechanism study on the regulation of intestinal microecology by hangover liver-protecting beverage for the treatment of alcoholic liver disease [J]. Food Sci Nutr, 2026, 14(1): e71435.
Huang N N, Wang M M, Peng J, et al. Role of arachidonic acid-derived eicosanoids in intestinal innate immunity [J]. Crit Rev Food Sci Nutr, 2021, 61(14): 2399-2410.

2026年第57卷第14期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.14.019

接收时间：2025-12-18
首发时间：2026-09-10

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-12-18

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.14.019

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT